Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | YL242 |
| Trade Name | |
| Synonyms | YL-242|YL 242 |
| Drug Descriptions |
YL242 is a non-internalized antibody-drug conjugate (ADC) comprising a VEGF antibody linked to a DNA topoisomerase I inhibitor by a protease-cleavable tripeptide that is cleaved in the tumor microenvironment, which potentially induces cytotoxicity in tumor cells and inhibits tumor growth (Cancer Res (2025) 85 (8_Supplement_1): 3140). |
| DrugClasses | VEGF Antibody 15 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Fluorouracil + Leucovorin + YL242 | Fluorouracil Leucovorin YL242 | 0 | 1 |
| Fluorouracil + Pembrolizumab + YL242 | Fluorouracil Pembrolizumab YL242 | 0 | 1 |
| Pembrolizumab + YL242 | Pembrolizumab YL242 | 0 | 1 |
| YL242 | YL242 | 0 | 1 |